Skip to main content

Table 4 Case mix of this study and the E-IMD study

From: Incidence, disease onset and short-term outcome in urea cycle disorders –cross-border surveillance in Germany, Austria and Switzerland

Disease name

E-IMD study Patients (n, %)

E-IMD study, age of diagnosis below 16 yearsa Patients (n, %)

This study Patients (n, %)

NAGS-D

9 (2%)

7 (2%)

0

CPS1-D

21 (5%)

20 (5%)

8 (16%)

mOTC-D

109 (24%)

95 (25%)

17 (34%)

fOTC-D

146 (32%)

98 (26%)

5 (10%)

ASS-D

87 (19%)

82 (22%)

10 (20%)

ASL-D

61 (13%)

56 (15%)

7 (14%)

ARG1-D

12 (3%)

12 (3%)

1 (2%)

HHH syndrome

11 (2%)

9 (2%)

1 (2%)

Citrin-Db

n/a

n/a

1 (2%)

Total

456 (100%)

379 (100%)

50 (100%)

  1. aUsing the same age cut-off as in the present study
  2. bCitrin deficiency was excluded from the analysis since this disease is not included in the E-IMD study [5]